These findings are consistent with those reported by Nakatsuka et al. [14], who observed significantly lower hepatic PEMT expression in NASH patients compared to those with simple steatosis, suggesting that diminished PEMT expression may contribute to worse liver manifestations in a subset of NAFLD patients. This evidence concerns the gene PEMT and steatosis.